Therefore, our work clearly demonstrates that BMI1 protein can be present in several hematological malignancies, but that only in CD26+ cells (thus CML LSCs) it is co-expressed with the BCR-ABL1 fusion protein. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.